Covestor’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$171K Buy
442
+100
+29% +$37.1K 0.1% 162
2026
Q1
$100K Sell
342
-365
-52% -$120K 0.07% 290
2025
Q4
$248K Sell
707
-179
-20% -$60.5K 0.13% 150
2025
Q3
$286K Buy
886
+398
+82% +$124K 0.16% 94
2025
Q2
$190K Sell
488
-161
-25% -$64.8K 0.11% 206
2025
Q1
$282K Buy
649
+149
+30% +$59.8K 0.19% 62
2024
Q4
$185K Sell
500
-1
-0.2% -$418 0.12% 205
2024
Q3
$261K Buy
501
+22
+5% +$11.8K 0.16% 88
2024
Q2
$260K Sell
479
-14
-3% -$7.4K 0.17% 92
2024
Q1
$256K Buy
493
+61
+14% +$30.3K 0.16% 80
2023
Q4
$204K Sell
432
-19
-4% -$8.79K 0.14% 135
2023
Q3
$197K Buy
451
+44
+11% +$20K 0.15% 112
2023
Q2
$181K Sell
407
-20
-5% -$9.23K 0.14% 152
2023
Q1
$196K Buy
427
+90
+27% +$42.8K 0.17% 111
2022
Q4
$173K Sell
337
-53
-14% -$26.9K 0.14% 163
2022
Q3
$177K Buy
390
+121
+45% +$57.9K 0.16% 101
2022
Q2
$129K Sell
269
-38
-12% -$18.8K 0.1% 267
2022
Q1
$151K Buy
307
+129
+72% +$59K 0.1% 268
2021
Q4
$83K Buy
+178
New +$74.9K 0.12% 249

Other funds holding ELV

Covestor's ELV Position: Q2 2026 in Review

Covestor increased its Elevance Health (ELV) stake by 29% in Q2 2026, buying an estimated $37.1K and bringing the position to 442 shares worth $171K. The position accounts for 0.1% of the portfolio, ranked #162.

Covestor first reported a position in ELV in Q4 2021 and has held it in 19 quarters since. The position peaked at $286K in Q3 2025. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Covestor held 442 shares of Elevance Health worth $171K as of Q2 2026.
  • Covestor bought 100 Elevance Health shares in Q2 2026, an estimated $37.1K.
  • Elevance Health made up 0.1% of Covestor's portfolio in Q2 2026, its #162 holding.
  • Covestor first reported a position in Elevance Health in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Elevance Health position peaked at $286K in Q3 2025.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.